CONMED CNMD Europe, Middle East & Africa — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about CONMED's europe, middle east & africa — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CONMED's europe, middle east & africa — net sales?
- CONMED (CNMD) reported europe, middle east & africa — net sales of $69.14M in Q1 2026.
- How has CONMED's europe, middle east & africa — net sales changed year-over-year?
- CONMED's europe, middle east & africa — net sales increased by 8.6% year-over-year, from $63.68M to $69.14M.
- What is the long-term trend for CONMED's europe, middle east & africa — net sales?
- Over 4 years (2021 to 2025), CONMED's europe, middle east & africa — net sales has grown at a 8.7% compound annual growth rate (CAGR), from $189.69M to $264.65M.
- What does europe, middle east & africa — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and equipment within the Europe, Middle East, and Africa geographic region. It serves as a key indicator of the company's international market penetration and demand for its surgical product portfolio outside of its primary domestic market. Tracking this figure allows investors to assess the company's geographic diversification and the success of its commercial strategy in these specific international territories.